Xenotransplantation;Xenotransplantation

Chirurg

Volumn 67, Issue 4, 1996, Pages 324-330

  White, D J G ^a   Calne, R Y ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Complement; Decay accelerating factor (DAF); Pig; Transgenic; Xenotransplantation

Indexed keywords

DECAY ACCELERATING FACTOR;

ANIMAL; COMPLEMENT ACTIVATION; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; IMMUNOLOGY; MALE; PERFUSION; PHYSIOLOGY; REVIEW; SWINE; TRANSGENIC ANIMAL; XENOGRAFT;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTIGENS, CD55; COMPLEMENT ACTIVATION; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; MALE; PERFUSION; SWINE; TRANSPLANTATION, HETEROLOGOUS;

EID: 0030118168     PISSN: 00094722     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Atkinson JP, Parries T (1987) Separation of self from non-self in the complement system. Immunol Today 8: 212
2. Brem G, Brenig B, Muller M, Krausslich H, Winnacker EL (1988) Production of transgenic pigs and possible application to pig breeding. Occ Publ Br Soc Anim Prod 12: 15
3. Broelsch C, Edmond J, Whitington P, Thistlethwaite J, et al (1990) Application of reduced-size liver transplants as split grafts, auxiliary orthotopic grafts, and living related segmental transplants. Ann Surg 212: 363
4. Caine N, O'Brien V (1989) Quality of life and psychological aspects of heart transplantation. In: Wallwork J (ed) Heart and heart-lung transplantation. Saunders, Philadelphia, p 389
5. Caine N, Sharples L, English T, Wallwork J (1990) Prospective study comparing quality of life before and after heart transplantation. Transplant Proc 22: 1437
6. Calne RY (1970) Organ transplantation between widely disparate species. Transplant Proc 2: 550
7. Calne RY, White DJG, Rolles K, et al (1979) Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases and 2 livers. Lancet II: 1033
8. Cary N, Moody J, Yannoutsos N, Wallwork J, White D (1993) Tissue expression of human decay accelerating factor, a regulator of complement activation expressed in mice: a potential approach to inhibition of hyperacute xenograft rejection. Transplant Proc 25: 400
9. Chiche L, Zuckman S, Mathieu D (1991) Xenotransplantation: baboons as potential liver donors. Transplant Proc 23:
10. Chirgwin J, Przybyla A, McDonald R, Rutter W (1979) Isolation of biologically active ribonucleic acid from sources rich in ribonuclease. Biochemistry 18: 5294
11. Dalmasso AP, Vercelloti GM, Platt JL, Bach FH (1991) Inhibition of complement mediated cytotoxicity by decay accelerating factor. Potential for prevention of xenograft hyperacute rejection. Transplantation 52: 530
12. Erickson H, Faraci F, Olsen S (1985) Effect of exercise on cardiopulmonary function in domestic pigs. In: Tumbleson M (ed) Swine in biomedical research. Plenum, New York
13. Forty J, Hasan R, Cary N, White DJ, Wallwork J (1992) Hyperacute rejection of rabbit hearts by human blood is mediated by the alternative pathway of complement. Transplant Proc 24: 488
14. Forty J, Hasan R, Cary N, White DJ, Wallwork J (1992) Perfusion of rabbit hearts with human blood results in immediate graft thrombosis, which is temporally distinct from hyperacute rejection. Transplant Proc 24: 610
15. Forty J, White DJG, Wallwork J (1993) A technique for perfusion of an isolated working heart to investigate hyperacute discordant xenograft rejection. J Thorac Cardiovasc Surg 106: 308
16. Giles G, Boehmig H, Amemiya H, Halgrimson C, Starzl T (1970) Clinical heterotransplantation of the liver. Transplant Proc 2: 506
17. Goldsmith M (1990) Mother to child: first living donor lung transplant. JAMA 264: 2724
18. Goodall J (1989) Ethical concerns in the use of animals as donors. In: Hardy M (ed) Xenograft 25. Elsevier, New York, p 335
19. Hannon J (1985) Haemodynamic characteristics of the conscious resting pig. In: Tumbleson M (ed) Swine in biomedical research. Plenum, New York, p 1341
20. Hoffenberg R (1987) Working party on the supply of donor organs for transplantation. HMSO
21. Jaboulay M (1906) Greffe de reins au pli du coude par soudures arterielles et veineuses. Lyon Med 107: 575
22. Johnston PS, Wang MW, Lim SM, Wright LJ, White DJ (1992) Discordant xenograft rejection in an antibody-free model. Transplantation 54: 573
23. Kaye M (1992) The registry of the International Society for Heart and Lung Transplantation. Ninth Official Report, 1992. J Heart Lung Transplant 11: 599
24. Kirkman R (1989) Of swine and men: organ physiology in different species. In: Hardy M (ed) Xenograft 25. Elsevier, New York, p 125
25. Lawick-Goodall J (1971) In the shadow of man. William Collins, Glasgow
26. Lublin DM, Coyne KE (1991) Phospholipid-anchored and transmembrane versions of either decay-accelerating factor or membrane cofactor protein show equal efficiency in protection from complement-mediated cell damage. J Exp Med 174: 35
27. McMaster P (1992) Pros and cons of living related organ donors in liver transplantation. Transpl Int
28. Miyagawa S, Hirose H, Shirakura R, et al (1988) The mechanism of discordant xenograft rejection. Transplantation 46: 825
29. Murray J, Merrill J, Harrison J (1955) Renal homotransplantation in identical twins. Surg Forum 6: 432
30. Najarian J, Frey D, Matas A (1990) Renal transplantation in infants. Ann Surg 212: 353
31. Nose M, Katoh M, Okada N, Kyogoku M, Okada H (1990) Tissue distribution of HRF20, a novel factor preventing the membrane attack of homologous complement, and its predominant expression on endothelial cells in vivo. Immunology 70: 145
32. Ogden D, Sitprija V, Holmes J (1965) Function of the baboon renal heterograft in man and comparison with renal homograft function. J Lab Clin Med 65: 370
33. Oglesby TJ, Allen CJ, Liszewski MK, White DJ, Atkinson JP (1992) Membrane cofactor protein (CD46) protects cells from complement-mediated attack by an intrinsic mechanism. J Exp Med 175: 1547
34. Paul LC (1991) Mechanism of humoral xenograft rejection. In: Cooper DKC, Kemp E, Reemtsma K, White DJG (eds) Xenografting. The transplantation of organs and tissues between species. Springer, Berlin Heidelberg New York, p 47
35. Perper RJ, Najarian JS (1966) Experimental renal heterotransplantation in widely divergent species. Transplantation 4: 377
36. Platt JL, Vercellotti GM, Dalmasso AP, et al (1990) Transplantation of discordant xenografts: a review of progress. Immunol Today 11: 450
37. Pursel VG, Pinkert CA, Miller KF, et al (1989) Genetic engineering of livestock. Science 244: 1281
38. Rey-Campos J, Rubinstein P, Rodriguez-de-Cordoba S (1988) A physical map of the human regulator of complement activation gene cluster linking the complement genes CR 1, CR2, DAF, and C4BP. J Exp Med 167: 664
39. Rosengard AM, Cary NRB, Langford GA, Tucker AW, et al (1995) Tissue expression of human complement inhibitor, decay-accelerating factor, in transgenic pigs - A potential approach for preventing xenograft rejection. Transplantation 59: 1325
40. Sanfilippo E (1989) The use of non-human primates in xenotransplantation. In: Hardy M (ed) Xenograft 25. Elsevier, New York, p 335
41. Schilling A, Land W, Pratschke E, Brendel W (1976) Dominant role of complement in the hyeracute xenograft rejection reaction. Surg Gynecol Obstet 142: 29
42. Shaw L, Miller J, Slutsky A (1991) Ethics of lung transplantation with live donors. Lancet 338: 678
43. Unger E (1910) Nierentransplantationen. Klin Wochenschr 47: 573
44. White DJG, Oglesby TJ, Tedja I, et al (1992) Human decay accelerating factor or membrane cofactor protein inhibit cross spevies mouse cell lysis by human complement. Transpl Int 5: 648